World's Best Scientists 2026 revealed!
Pierre-Yves Bochud

Pierre-Yves Bochud

D-Index & Metrics

Microbiology

D-Index
58
Citations
14546
World Ranking
3391
National Ranking
76

Pierre-Yves Bochud publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Pierre-Yves Bochud sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 173 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Pierre-Yves Bochud D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre-Yves Bochud sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 58 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Pierre-Yves Bochud is affiliated with the University of Lausanne in Switzerland. Their research primarily focuses on the field of Medicine with a significant emphasis on Infectious Diseases and related subfields.

Their scientific contributions encompass key topics including:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Renal transplantation outcomes and treatments
  • SARS-CoV-2 and COVID-19 research
  • COVID-19 clinical research studies
  • Neutropenia and cancer infections

Bochud has authored numerous publications in varied peer-reviewed journals, with frequent contributions to the following venues:

  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • American Journal of Transplantation
  • BMC Infectious Diseases
  • JAMA Network Open

Among recent notable papers are:

  • Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia (2020, JAMA)
  • Risk factors for candidemia: a prospective matched case-control study (2020, Critical Care)
  • Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer (2022, Clinical Infectious Diseases)
  • Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa (2020, Antimicrobial Agents and Chemotherapy)
  • Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients (2021, Frontiers in Immunology)

They have collaborated extensively with several co-authors in their research work. Frequent collaborators include:

  • Oriol Manuel
  • Frédéric Lamoth
  • Nicolas J. Mueller
  • Patrizia Amico
  • Heiner C. Bucher

Bochud's scholarly activity reflects an integrated approach combining epidemiology, infectious diseases, oncology, surgery, and transplantation studies. This multidisciplinary focus supports research into clinical infections, antimicrobial resistance, and transplant outcomes, particularly within immunocompromised and neutropenic patient populations.

Best Publications

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation

    Pierre-Yves Bochud;Jason W. Chien;Kieren A. Marr;Kieren A. Marr;Wendy M. Leisenring;Wendy M. Leisenring

  • Whole-genome sequencing reveals host factors underlying critical COVID-19

    Unknown

  • Pathogenesis of sepsis: new concepts and implications for future treatment

    Pierre-Yves Bochud;Thierry Calandra

  • Bacteremia due to viridans streptococci in neutropenic patients: A review

    Pierre-Yves Bochud;Thierry Calandra;Patrick Francioli

  • Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

    Pierre-Yves Bochud;Pierre-Yves Bochud;Tao Cai;Tao Cai;Kathrin Stéphanie Overbeck;Murielle Bochud

  • Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk Factors

    P.-Y. Bochud;Ph. Eggiman;Th. Calandra;G. Van Melle

  • Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling

    Pierre-Yves Bochud;Thomas R. Hawn;Thomas R. Hawn;Alan Aderem;Alan Aderem

  • Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response than IL28B Genotype in Patients with Hepatitis C

    Michael T. Dill;Michael T. Dill;Francois H.T. Duong;Julia E. Vogt;Stéphanie Bibert

  • Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.

    Pierre-Yves Bochud;Marc Bonten;Oscar Marchetti;Thierry Calandra

  • Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study

    Christian van Delden;Susanne Stampf;Hans H Hirsch;Hans H Hirsch;Oriol Manuel

  • Antibiotics in sepsis

    Pierre-Yves Bochud;Michel P. Glauser;Thierry Calandra

  • Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.

    Elodie von Dach;Werner C. Albrich;Anne-Sophie Brunel;Virginie Prendki

  • IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

    Stéphanie Bibert;Thierry Roger;Thierry Calandra;Murielle Bochud

  • A first update on mapping the human genetic architecture of COVID-19

    Unknown

  • Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.

    Pierre Yves Bochud;Martin Hersberger;Patrick Taffé;Murielle Bochud

  • Community-acquired pneumonia. A prospective outpatient study.

    Pierre-yves Bochud;FranÇois Moser;Philippe Erard;FranÇois Verdon

  • Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

    Etienne Patin;Etienne Patin;Zoltán Kutalik;Zoltán Kutalik;Julien Guergnon;Stéphanie Bibert

  • Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis.

    Aline Valeska Probst;T Dang;Murielle Bochud;M Egger

  • ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.

    Cesaro S;Dalianis T;Hanssen Rinaldo C;Koskenvuo M

  • Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.

    Martin Lagging;Galia Askarieh;Francesco Negro;Stephanie Bibert

  • IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes†‡§

    Pierre-Yves Bochud;Stéphanie Bibert;Zoltán Kutalik;Zoltán Kutalik;Etienne Patin;Etienne Patin

  • Toll-Like Receptor 2 (TLR2) Polymorphisms Are Associated with Reversal Reaction in Leprosy

    Pierre Yves Bochud;Thomas R. Hawn;M. Ruby Siddiqui;Paul Saunderson

  • IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study

    Vijayaprakash Suppiah;Silvana Gaudieri;Nicola J. Armstrong;Kate S. O'Connor

Frequent Co-Authors

Zoltán Kutalik
Zoltán Kutalik University of Lausanne
Markus H. Heim
Markus H. Heim University Hospital of Basel
Francesco Negro
Francesco Negro University of Geneva
Thierry Calandra
Thierry Calandra University of Lausanne
Darius Moradpour
Darius Moradpour University of Lausanne
Frédéric Lamoth
Frédéric Lamoth University Hospital of Lausanne
Andreas Cerny
Andreas Cerny University of Bern
Hans H. Hirsch
Hans H. Hirsch University Hospital of Basel
Jean-François Dufour
Jean-François Dufour University of Bern
Christian van Delden
Christian van Delden University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology not only opens doors to traditional laboratory roles but also connects to diverse healthcare and information management careers. For students interested in blending healthcare with administrative expertise, obtaining an online health information management degree programs cahiim accredited is a popular choice. These programs provide essential skills for managing medical records and healthcare data effectively.

For those seeking quicker entry into the health information field, exploring the quickest medical billing and coding certificate online options allows for rapid certification and employment. These certificates help professionals specialize in translating patient data into billing codes quickly and accurately.

Additionally, becoming a certified professional coder (cpc) offers a career path that combines technical coding knowledge with healthcare billing systems, leading to competitive salaries and stable job opportunities.

Graduates holding a health information management degree can expect attractive compensation, as highlighted in the overview of the health information management bachelor degree salary. This field offers growth potential through roles that require both scientific understanding and data expertise.

Best Scientists Citing Pierre-Yves Bochud

Trending Scientists